For Immediate Release: June 28, 2021
REDITUS, ROSSI, RECOGNIZED BY STATE
PEKIN – Reditus Laboratories and its CEO, Dr. Aaron Rossi, have been honored by the State of Illinois for contributions to Pekin and the entire state during the COVID-19 pandemic. State Rep. Mark Luft, R-Pekin, on Monday presented Rossi with two certifications of recognition from the Illinois General Assembly.
The first recognized Reditus for its contributions to Pekin and the State of Illinois for promoting safety and community support during the COVID-19 pandemic. Since April 2020, Reditus has performed more than 2.4 million tests for SARS-CoV-2 (COVID-19) using gold-standard PCR (polymerase chain reaction) testing.
The second certificate recognized Rossi for his dedication and efforts in creating jobs during the COVID-19 pandemic. Reditus, which opened in June 2019, has nearly 300 employees.
Luft recalled that after he became Pekin mayor, he met with Rossi to discuss Rossi’s plans for Reditus and how the company pivoted to provide COVID testing in spring 2020.
“I personally am aware of how much effort and work Aaron has put into this community and the surrounding communities for the last 15 months,” Luft said. “Thanks to Dr. Aaron Rossi and Reditus Laboratories, our community stayed safer.”
Luft said it was a good time in the COVID “journey” to recognize Rossi and Reditus. Rossi thanked Luft. “I always knew I had the support of the city and mayor,” Rossi said.
But Rossi said the credit goes to Reditus employees, including his wife, Molly Rossi, who also is Reditus vice president of clinical logistics.
“I am impressed every day with the dedication of our employees and their recognition that everything we do is for the patient,” Rossi said
Reditus Laboratories is a full-service laboratory company with a heavy focus on molecular diagnostics. Based in Pekin, Illinois, Reditus provides top-tier, accurate anatomical and clinical pathology services, including cytology, histology and molecular testing. Reditus is accredited by the College of American Pathologists (CAP) and is certified by the Clinical Laboratory Improvement Amendments (CLIA) program. Additional information is at www.redituslabs.com, as well as on Facebook at Reditus Laboratories and Twitter @ReditusLabs